Overview
- Natural killer T (NKT) cells discussed in this book are CD1d-restricted T cells
- Overview of structures and functions of glycolipid antigens
- Explains roles of NKT cells in human lymphoma patients
- Includes supplementary material: sn.pub/extras
Part of the book series: Cancer Drug Discovery and Development (CDD&D)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (11 chapters)
Keywords
About this book
Reviews
From the reviews:
“This book is essentially a collection of reviews that introduce the reader to the wonderful world of iNKT cells, and how their powerful adjuvant properties are being utilised by different researchers. … this book is worth reading whether you are a new student in the NKT field and want to learn more or whether you are a clinician with an interest in tumour immunology.” (Salah Mansour, Immunology News, November, 2012)Editors and Affiliations
Bibliographic Information
Book Title: Natural Killer T cells
Book Subtitle: Balancing the Regulation of Tumor Immunity
Editors: Masaki Terabe, Jay A. Berzofsky
Series Title: Cancer Drug Discovery and Development
DOI: https://doi.org/10.1007/978-1-4614-0613-6
Publisher: Humana New York, NY
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer Science+Business Media, LLC 2012
Hardcover ISBN: 978-1-4614-0612-9Published: 21 September 2011
Softcover ISBN: 978-1-4614-2950-0Published: 25 October 2013
eBook ISBN: 978-1-4614-0613-6Published: 22 September 2011
Series ISSN: 2196-9906
Series E-ISSN: 2196-9914
Edition Number: 1
Number of Pages: XII, 208
Topics: Cancer Research, Pharmacology/Toxicology